Carmichael Hill & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Carmichael Hill & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$29.7K	Hold	48	–	–	0.01%	447
2024 Q2	$26.5K	Hold	48	–	–	0.01%	443
2024 Q1	$27.9K	Hold	48	–	–	0.01%	433
2023 Q4	$25.5K	Hold	48	–	–	0.01%	439
2023 Q3	$24.3K	Sell	48 -19	-28%	-$10.1K	0.01%	441
2023 Q2	$35K	Hold	67	–	–	0.02%	392
2023 Q1	$38.6K	Hold	67	–	–	0.02%	362
2022 Q4	$36.9K	Hold	67	–	–	0.02%	389
2022 Q3	$34K	Hold	67	–	–	0.02%	398
2022 Q2	$36K	Hold	67	–	–	0.02%	386
2022 Q1	$40K	Hold	67	–	–	0.02%	405
2021 Q4	$45K	Hold	67	–	–	0.02%	389
2021 Q3	$38K	Hold	67	–	–	0.02%	415
2021 Q2	$34K	Hold	67	–	–	0.02%	430
2021 Q1	$31K	Hold	67	–	–	0.02%	428
2020 Q4	$31K	Hold	67	–	–	0.02%	400
2020 Q3	$30K	Hold	67	–	–	0.02%	376
2020 Q2	$24K	Hold	67	–	–	0.02%	392
2020 Q1	$19K	Hold	67	–	–	0.02%	381
2019 Q4	$22K	Buy	+67	New	+$20.3K	0.02%	394

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carmichael Hill & Associates's TMO Position: Q3 2024 in Review

Carmichael Hill & Associates held its Thermo Fisher Scientific (TMO) position steady in Q3 2024 at 48 shares worth $29.7K. The position accounts for 0.01% of the portfolio, ranked #447.

Carmichael Hill & Associates first reported a position in TMO in Q4 2019 and has held it in 20 quarters since. The position peaked at $45K in Q4 2021. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Carmichael Hill & Associates held 48 shares of Thermo Fisher Scientific worth $29.7K as of Q3 2024.
Carmichael Hill & Associates left its Thermo Fisher Scientific share count unchanged in Q3 2024.
Thermo Fisher Scientific made up 0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #447 holding.
Carmichael Hill & Associates first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 20 quarters since.
Carmichael Hill & Associates's Thermo Fisher Scientific position peaked at $45K in Q4 2021.
2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.